OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
DRRSF
Arianne Phosphate Inc
Ordinary Shares
0.12
-0.0093
-7.19%
0.1092 / 0.17 (5000 x 5000)
Real-Time Best Bid & Ask: 07:10am 07/18/2025
Delayed (15 Min) Trade Data: 12:00am 07/17/2025
Filings and Disclosure
OTC Disclosure & News Service
Active
Inactive
All
Publish Date Publish Date | Title Title | Period End Date Period End Date | Status Status |
|---|---|---|---|
| 12/06/2024 | Management Discussion and Analysis | 09/30/2024 | A |
| 12/06/2024 | Interim Financial Report | 09/30/2024 | A |
| 08/29/2024 | Management Discussion and Analysis | 06/30/2024 | A |
| 08/29/2024 | Interim Financial Report | 06/30/2024 | A |
| 05/30/2024 | Management Discussion and Analysis | 03/31/2024 | A |
| 05/30/2024 | Quarterly Report | 03/31/2024 | A |
| 04/24/2024 | Management Discussion and Analysis | 12/31/2023 | A |
| 04/24/2024 | Annual Report | 12/31/2023 | A |
| 11/30/2023 | Management Discussion and Analysis | 09/30/2023 | A |
| 11/30/2023 | Quarterly Report | 09/30/2023 | A |
More
Displaying 10 of 42 Disclosure & News
SEDAR+™ Filings
Publish Date Publish Date | Document Document | Period End Date Period End Date |
|---|---|---|
| 06/25/2025 | News release - English | 06/25/2025 |
| 05/21/2025 | 52-109FV2 - Certification of interim filings - CEO (E) | 03/31/2025 |
| 05/21/2025 | Interim financial statements/report – English | 03/31/2025 |
| 05/21/2025 | Interim MD&A - English | 03/31/2025 |
| 05/21/2025 | 52-109FV2 - Certification of interim filings - CFO (E) | 03/31/2025 |
| 04/30/2025 | 52-109FV1 - Certification of annual filings - CFO (E) | 12/31/2024 |
| 04/30/2025 | Audited annual financial statements – English | 12/31/2024 |
| 04/30/2025 | 52-109FV1 - Certification of annual filings - CEO (E) | 12/31/2024 |
| 04/30/2025 | AB Form 13-501F1 and/or ON Form 13-502F1 (Class 1 and 3B Reporting Issuers - Participation Fee) | 12/31/2024 |
| 04/30/2025 | Annual MD&A - English | 12/31/2024 |
More
Displaying 10 of 28 SEDAR+ Filings
SEC Filings
Insider Disclosure
OTC Disclosure & News
No insider disclosure available for DRRSF.
SEC Transactions Last 6 Months
Buy / Sell
Buys
0Sells
0Total
0Shares
Bought
0Sold
0Gross
0Net
0SEC Transactions Last 2 Years
No SEC transactions available for DRRSF.
Joined OTCQX 09/2022
The Company Profile data was verified by the issuer within the previous 6 months.
This security is not a Penny Stock as defined in SEC Rule 240.3a51-1.
This company has certified to OTC Markets Group that it is eligible to rely on the exemption from registration under Securities and Exchange Act Rule 12g3-2(b).
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
The Company’s board of directors includes at least two Independent Directors.
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.
Loading...
Symbol
OTCM
Last
57.50
Change
0.50 (0.88%)
Bid
56.65
Ask
59.99
Volume
17414
Time
00:00
